Active, Not Recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
NCT04755283
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +10 more
- Locations
-
- Anthos Investigative Site Huntsville, Alabama, United States
- Anthos Investigative Site Mobile, Alabama, United States
- Anthos Investigative Site Stamford, Connecticut, United States
- Anthos Investigative Site Clearwater, Florida, United States